CN Stock MarketDetailed Quotes
603566 Pulike Biological Engineering,Inc.
- 13.35
- +0.43+3.33%
Market Closed Dec 27 15:00 CST
4.62BMarket Cap45.41P/E (TTM)
13.51High12.84Low61.32KlotVolume12.93Open12.92Pre Close81.30MTurnover1.77%Turnover Ratio26.49P/E (Static)346.06MShares24.6052wk High1.75P/B4.62BFloat Cap10.8052wk Low14.21Limit Up346.06MShs Float40.48Historical High11.63Limit Down5.19%Amplitude8.36Historical Low0.40Dividend TTM13.26Avg Price24.86KlotAsk3.00%Div YieldTTM100Lot Size35.58KlotBid
Pulike Biological Engineering,Inc. Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -17.96%761.74M | -21.82%483.15M | -23.27%235.49M | 1.84%1.25B | 12.25%928.54M | 20.53%617.98M | 25.12%306.91M | 11.97%1.23B | 0.76%827.23M | -11.48%512.71M |
| Operating revenue | -17.96%761.74M | -21.82%483.15M | -23.27%235.49M | 1.84%1.25B | 12.25%928.54M | 20.53%617.98M | 25.12%306.91M | 11.97%1.23B | 0.76%827.23M | -11.48%512.71M |
| Other operating revenue | ---- | -33.22%4.4M | ---- | -22.59%10.11M | ---- | 33.99%6.59M | ---- | 18.48%13.06M | ---- | -0.07%4.92M |
| Total operating cost | -11.46%654.45M | -15.49%406.84M | -14.88%205.18M | 1.54%1.05B | 9.81%739.13M | 16.48%481.44M | 20.79%241.06M | 19.42%1.03B | 13.52%673.07M | 3.18%413.34M |
| Operating cost | -21.13%280.73M | -25.11%177.88M | -33.79%83.81M | 6.23%488.4M | 15.64%355.93M | 22.68%237.52M | 35.27%126.58M | 21.00%459.74M | 14.60%307.79M | 3.35%193.6M |
| Operating tax surcharges | 15.37%12.25M | 13.00%7.94M | 6.73%3.94M | 14.49%14.62M | 20.60%10.62M | 24.42%7.02M | 32.94%3.69M | 13.07%12.77M | 4.04%8.81M | -4.46%5.65M |
| Operating expense | -17.04%209.78M | -18.34%134.37M | -17.47%63.4M | -4.12%352.03M | 5.06%252.88M | 13.15%164.54M | 17.94%76.82M | 22.37%367.16M | 17.91%240.71M | 6.29%145.41M |
| Administration expense | 37.58%84.17M | 31.95%44.89M | 106.97%34.27M | -8.05%98M | -10.65%61.18M | -25.78%34.02M | -26.28%16.56M | 16.05%106.58M | 28.36%68.47M | 41.30%45.84M |
| Financial expense | 43.81%-1.48M | 10.90%-1.19M | -1,793.07%-706.4K | 18.22%-3.23M | -32.57%-2.63M | -84.71%-1.33M | 80.76%-37.31K | -91.71%-3.94M | -5.78%-1.99M | 50.54%-722.04K |
| -Interest expense (Financial expense) | ---- | ---- | ---- | 7.36%922.16K | 23.73%823.64K | 78.60%770.96K | 688.80%763.05K | --858.98K | --665.68K | --431.67K |
| -Interest Income (Financial expense) | 48.05%-1.69M | 40.07%-1.1M | 46.80%-602.02K | 7.34%-4.13M | -67.33%-3.25M | -95.77%-1.84M | -307.61%-1.13M | -78.10%-4.45M | 6.93%-1.94M | 44.00%-937.4K |
| Research and development | 12.81%68.99M | 8.27%42.95M | 17.31%20.46M | 9.15%101.1M | 24.08%61.16M | 68.40%39.67M | 10.37%17.44M | 8.24%92.62M | -18.20%49.29M | -40.47%23.56M |
| Credit Impairment Loss | -76.09%1.36M | -86.54%233.22K | -86.93%381.82K | -19.56%-23.86M | 171.67%5.67M | 128.09%1.73M | 180.89%2.92M | -142.12%-19.96M | -117.14%-7.91M | -7.82%-6.17M |
| Asset Impairment Loss | ---1.16M | ---792.73K | ---- | ---32.22K | ---- | ---- | ---427.88K | ---- | ---- | ---- |
| Other net revenue | -7.90%8.29M | 167.28%4.07M | -90.72%875.76K | 51.90%-8.77M | 168.90%9M | 19.99%-6.05M | 326.89%9.44M | -134.62%-18.22M | -186.60%-13.07M | -5,543.40%-7.56M |
| Fair value change income | 83.61%-4.92M | 79.72%-4.79M | 40.70%-2.59M | 30.81%-17.69M | -806.44%-30M | -829.86%-23.63M | -2,309.15%-4.36M | -225.28%-25.57M | -171.80%-3.31M | -122.07%-2.54M |
| Invest income | -68.51%6.5M | -42.97%5.32M | -89.49%777.05K | 213.20%17.66M | 247.24%20.63M | 225.77%9.33M | 847.40%7.4M | 35,699.90%5.64M | -279.74%-14.01M | -239.44%-7.42M |
| -Including: Investment income associates | -269.46%-4.22M | -428.84%-2.95M | -151.27%-583.8K | 55.97%-8.86M | 114.50%2.49M | 94.51%-557.44K | 130.58%1.14M | -140.30%-20.13M | -3,830.44%-17.19M | -1,755.51%-10.15M |
| Asset deal income | -171.04%-132.31K | -38.38%-72.74K | -48.67%-8.01K | -96.80%-405.91K | -4,937.17%-48.82K | -271.47%-52.57K | -111.07%-5.39K | 71.10%-206.26K | 99.86%-969.13 | 107.34%30.66K |
| Other revenue | -47.82%6.65M | -36.56%4.18M | -40.95%2.31M | -28.86%15.56M | 4.76%12.75M | -22.91%6.58M | 581.25%3.91M | -46.94%21.87M | 73.57%12.17M | 366.18%8.54M |
| Operating profit | -41.74%115.59M | -38.40%80.38M | -58.58%31.19M | 9.10%193.01M | 40.63%198.41M | 42.13%130.49M | 81.10%75.29M | -37.83%176.92M | -41.98%141.09M | -48.56%91.81M |
| Add:Non operating Income | 35.36%1.97M | 1,765.02%1.9M | 140.50%188.76K | -4.27%2.17M | 4,408.85%1.46M | 376.78%101.71K | 7,008.52%78.49K | -11.02%2.27M | -99.84%32.33K | -99.84%21.33K |
| Less:Non operating expense | -50.00%441.87K | 174.60%408.69K | 17,015.69%309.65K | -60.93%571.59K | 7.28%883.74K | -24.31%148.83K | -91.10%1.81K | -50.51%1.46M | -25.87%823.74K | -76.74%196.64K |
| Total profit | -41.14%117.12M | -37.24%81.87M | -58.78%31.06M | 9.51%194.61M | 41.83%198.99M | 42.35%130.45M | 81.37%75.37M | -37.46%177.72M | -46.40%140.3M | -52.12%91.64M |
| Less:Income tax cost | -45.44%10.84M | -44.99%7.92M | -66.82%3.76M | 102.99%20.1M | 63.42%19.88M | 26.52%14.4M | 181.03%11.33M | -75.27%9.9M | -60.94%12.16M | -59.03%11.38M |
| Net profit | -40.67%106.27M | -36.28%73.95M | -57.36%27.31M | 3.99%174.52M | 39.78%179.11M | 44.59%116.05M | 70.67%64.04M | -31.26%167.82M | -44.44%128.14M | -50.94%80.26M |
| Net profit from continuing operation | -40.67%106.27M | -36.28%73.95M | -57.36%27.31M | 3.99%174.52M | 39.78%179.11M | 44.59%116.05M | 70.67%64.04M | -31.26%167.82M | -44.44%128.14M | -50.94%80.26M |
| Net profit of parent company owners | -40.67%106.27M | -36.28%73.95M | -57.36%27.31M | 3.99%174.52M | 39.78%179.11M | 44.59%116.05M | 70.67%64.04M | -31.26%167.82M | -44.44%128.14M | -50.94%80.26M |
| Earning per share | ||||||||||
| Basic earning per share | -40.38%0.31 | -38.24%0.21 | -57.89%0.08 | -3.85%0.5 | 26.83%0.52 | 30.77%0.34 | 58.33%0.19 | -33.33%0.52 | -43.84%0.41 | -50.00%0.26 |
| Diluted earning per share | -40.38%0.31 | -38.24%0.21 | -57.89%0.08 | -3.85%0.5 | 26.83%0.52 | 30.77%0.34 | 58.33%0.19 | -33.33%0.52 | -43.84%0.41 | -50.00%0.26 |
| Other composite income | ||||||||||
| Total composite income | -40.67%106.27M | -36.28%73.95M | -57.36%27.31M | 3.99%174.52M | 39.78%179.11M | 44.59%116.05M | 70.67%64.04M | -31.26%167.82M | -44.44%128.14M | -50.94%80.26M |
| Total composite income of parent company owners | -40.67%106.27M | -36.28%73.95M | -57.36%27.31M | 3.99%174.52M | 39.78%179.11M | 44.59%116.05M | 70.67%64.04M | -31.26%167.82M | -44.44%128.14M | -50.94%80.26M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
